The SATCM Key Laboratory for New Resources & Quality Evaluation of Chinese Medicine, The MOE Key Laboratory for Standardization of Chinese Medicines and Shanghai Key Laboratory of Compound Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
Microb Cell Fact. 2019 Feb 8;18(1):34. doi: 10.1186/s12934-019-1076-2.
Bear bile powder is a valuable medicinal material characterized by high content of tauroursodeoxycholic acid (TUDCA) at a certain ratio to taurochenodeoxycholic acid (TCDCA). We had created an engineered E. coli harboring two-step bidirectional oxidative and reductive enzyme-catalyzing pathway that could rapidly convert TCDCA to TUDCA at a specific percentage in shake flasks.
We reported here the large-scale production of TUDCA containing products by balancing the bidirectional reactions through optimizing fermentation process of the engineered E. coli in fermenters. The fermentation medium was firstly optimized based on M9 medium using response surface methodology, leading to a glycerol and yeast extract modified M9-GY medium benefits for both cell growth and product conversion efficiency. Then isopropylthio-β-galactoside induction and fed-stock stage was successively optimized. Finally, a special deep-tank static process was developed to promote the conversion from TCDCA to TUDCA. Applying the optimal condition, fermentation was performed by separately supplementing 30 g refined chicken bile powder and 35 g crude chicken bile powder as substrates, resulting in 29.35 ± 2.83 g and 30.78 ± 3.04 g powder products containing 35.85 ± 3.85% and 27.14 ± 4.23% of TUDCA at a ratio of 1.49 ± 0.14 and 1.55 ± 0.19 to TCDCA, respectively, after purification and evaporation of the fermentation broth. The recovery yield was 92.84 ± 4.21% and 91.83 ± 2.56%, respectively.
This study provided a practical and environment friendly industrialized process for producing artificial substitute of bear bile powder from cheap and readily available chicken bile powder using engineered E. coli microbial cell factory. It also put forward an interesting deep-tank static process to promote the enzyme-catalyzing reactions toward target compounds in synthetic biology-based fermentation.
熊胆粉是一种有价值的药用材料,其特征在于牛磺熊脱氧胆酸(TUDCA)与牛磺鹅脱氧胆酸(TCDCA)的特定比例的高含量。我们已经创建了一种工程大肠杆菌,其含有两步双向氧化和还原酶催化途径,可以在摇瓶中以特定百分比快速将 TCDCA 转化为 TUDCA。
我们在这里报道了通过在发酵罐中优化工程大肠杆菌的发酵过程来平衡双向反应,从而大规模生产含有 TUDCA 的产品。首先基于 M9 培养基使用响应面法优化发酵培养基,导致甘油和酵母提取物改良的 M9-GY 培养基有利于细胞生长和产物转化效率。然后成功优化异丙基硫代-β-半乳糖苷诱导和进料阶段。最后,开发了一种特殊的深罐静态过程来促进 TCDCA 向 TUDCA 的转化。应用最佳条件,分别补加 30 g 精制鸡胆粉和 35 g 粗鸡胆粉作为底物进行发酵,发酵液经纯化浓缩后得到的产品中 TUDCA 含量分别为 35.85±3.85%和 27.14±4.23%,TCDCA 与 TUDCA 的摩尔比分别为 1.49±0.14 和 1.55±0.19,得率分别为 92.84±4.21%和 91.83±2.56%。
本研究利用工程大肠杆菌微生物细胞工厂,从廉价易得的鸡胆粉中生产人工替代熊胆粉,提供了一种实用且环保的工业化生产工艺。它还提出了一种有趣的深罐静态过程,以促进基于合成生物学的发酵中目标化合物的酶催化反应。